PillDenosumab
Brands: Bomyntra · Conexxence · Jubbonti · Prolia +2 · Denosumab
3 active makers
soon
soon
soon
soon
US acquisition costNADAC · per unit
Average across 6 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
Who makes it3 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Amgen, Inc | unknown | 4 | SUPPLYING |
| Fresenius Kabi USA, LLC | unknown | 3 | SUPPLYING |
| Sandoz Inc | unknown | 2 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Apr 21, 2025RECALLRecall (Class II): PROLIA (denosumab), injection, 60mg/mL, For Subcutaneous Use Only, Rx Only, Manufactured by: Amgen Inc., Thousand Oaks,…
CGMP Deviations; potential temperature excursions due to transit delays — Recalling firm: Mckesson Medical-Surgical Inc. Corporate Office — Within the U.S - OH, VA, FL.
- Sep 17, 2013RECALLRecall (Class II): Prolia (denosumab) Injection, 60 mg/mL, 1 x 60 mg Single Use Prefilled Syringe per carton, Rx only, Manufactured by: Am…
Presence of Particulate Matter: Visible cellulose fibers were observed in a small number of prefilled syringes during a routine quality examination. — Recalling firm: Amgen, Inc. — Nationwide and Puerto Rico, Canada, Mexico, and clinical distribution in Europe.